The proceeds of the Transaction are expected to result in a total cumulative gross amount of at least EUR 7 million in immediate new funding for the Company. The Company could receive further proceeds ...

Publication in Nature highlights delivery of DNA vaccine with PharmaJet Needle-free IM System produces robust and durable ...